German chemicals, pharmaceuticals and life sciences group Merck entered a non-binding Memorandum of Understanding (MoU) with Afrigen Biologics to support the development...

Merck has agreed to acquire US life sciences company Mirus Bio for $600 million (around €550 million) from Gamma Biosciences, a life sciences platform established by...

Contract manufacturing and development organization (CDMO) Wacker Biotech US, a subsidiary of Germany’ Wacker Chemie specializing in the fermentative production of...

German chemical group Wacker announced that its mRNA competence center in Halle is to produce an active ingredient based on mRNA and lipid nanoparticles (LNPs) supplied...

mRNA-based vaccines against the coronavirus have become firmly established in medicine since the pandemic. Nevertheless, the technology is still at the beginning of its...

Swiss contract development and manufacturing organization (CDMO) Lonza will collaborate with Oxford Nanopore Technologies, a UK-based company delivering a new generation...

Merck is the first CTDMO (contract testing, development, and manufacturing organization) to offer an integrated service covering all critical phases of mRNA development...

US vaccine maker Moderna and German biotechnology company Immatics agreed on a broad multi-platform research and development collaboration for novel cancer therapies...